Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer
Clinical trial NCT06795191 · WITHDRAWN
Trial details
- NCT number
- NCT06795191
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.